Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

383 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reasons of not having breast reconstruction: a historical cohort of 1937 breast cancer patients undergoing mastectomy.
Héquet D, Zarca K, Dolbeault S, Couturaud B, Ngô C, Fourchotte V, De La Rochefordière A, Féron JG, Fitoussi A, Bélichard C, Reyal F, Laki F, Hajage D, Sigal B, Asselain B, Alran S; Institut Curie Breast Cancer Group, Roman Rouzier. Héquet D, et al. Among authors: asselain b. Springerplus. 2013 Jul 18;2:325. doi: 10.1186/2193-1801-2-325. eCollection 2013. Springerplus. 2013. PMID: 23961399 Free PMC article.
Breast and ovarian cancer risk management in a French cohort of 158 women carrying a BRCA1 or BRCA2 germline mutation: patient choices and outcome.
This P, de la Rochefordière A, Savignoni A, Falcou MC, Tardivon A, Thibault F, Alran S, Fourchotte V, Fitoussi A, Couturaud B, Dolbeault S, Salmon RJ, Sigal-Zafrani B, Asselain B, Stoppa-Lyonnet D; Institut Curie Breast and Ovarian Cancer Risk Study Group. This P, et al. Among authors: asselain b. Fam Cancer. 2012 Sep;11(3):473-82. doi: 10.1007/s10689-012-9539-1. Fam Cancer. 2012. PMID: 22711610 Clinical Trial.
Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma.
Reyal F, Hajage D, Savignoni A, Feron JG, Bollet MA, Kirova Y, Fourquet A, Pierga JY, Cottu P, Dieras V, Fourchotte V, Laki F, Alran S, Asselain B, Vincent-Salomon A, Sigal-Zafrani B, Sastre-Garau X. Reyal F, et al. Among authors: asselain b. PLoS One. 2013;8(3):e55901. doi: 10.1371/journal.pone.0055901. Epub 2013 Mar 19. PLoS One. 2013. PMID: 23526930 Free PMC article.
The patient-breast cancer care pathway: how could it be optimized?
Baffert S, Hoang HL, Brédart A, Asselain B, Alran S, Berseneff H, Huchon C, Trichot C, Combes A, Alves K, Koskas M, Nguyen T, Roulot A, Rouzier R, Héquet D. Baffert S, et al. Among authors: asselain b. BMC Cancer. 2015 May 12;15:394. doi: 10.1186/s12885-015-1417-4. BMC Cancer. 2015. PMID: 25963161 Free PMC article.
External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement.
Hajage D, de Rycke Y, Bollet M, Savignoni A, Caly M, Pierga JY, Horlings HM, Van de Vijver MJ, Vincent-Salomon A, Sigal-Zafrani B, Senechal C, Asselain B, Sastre X, Reyal F. Hajage D, et al. Among authors: asselain b. PLoS One. 2011;6(11):e27446. doi: 10.1371/journal.pone.0027446. Epub 2011 Nov 8. PLoS One. 2011. PMID: 22087319 Free PMC article.
[How to improve the surgical trials quality in daily practice].
Laas E, Feron JG, Laki F, Fourchotte V, Osdoit M, Asselain B, Reyal F, Lecuru F. Laas E, et al. Among authors: asselain b. Bull Cancer. 2022 Oct;109(10):1059-1065. doi: 10.1016/j.bulcan.2022.04.013. Epub 2022 Aug 19. Bull Cancer. 2022. PMID: 35995611 Review. French.
383 results